S. Van Der Linden

751 total citations
9 papers, 178 citations indexed

About

S. Van Der Linden is a scholar working on Immunology, Infectious Diseases and General Health Professions. According to data from OpenAlex, S. Van Der Linden has authored 9 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Infectious Diseases and 2 papers in General Health Professions. Recurrent topics in S. Van Der Linden's work include Health Systems, Economic Evaluations, Quality of Life (2 papers), Viral Infections and Vectors (2 papers) and Vector-borne infectious diseases (2 papers). S. Van Der Linden is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (2 papers), Viral Infections and Vectors (2 papers) and Vector-borne infectious diseases (2 papers). S. Van Der Linden collaborates with scholars based in Netherlands, China and United States. S. Van Der Linden's co-authors include C Bakker, Maureen Rutten‐van Mölken, Eddy van Doorslaer, Ivo de Blaauw, Ella van den Berg‐Loonen, Johannes J. Rasker, Ben A. C. Dijkmans, Paul A.D. Bouma, Désirée van der Heijde and Ron Winkens and has published in prestigious journals such as Annals of the Rheumatic Diseases, Medical Care and JAMA Network Open.

In The Last Decade

S. Van Der Linden

9 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Van Der Linden Netherlands 5 108 41 21 15 15 9 178
Katharina Elisabeth Fischer Germany 11 154 1.4× 60 1.5× 4 0.3× 22 1.5× 17 298
Marilyn Metcalf United States 5 111 1.0× 97 2.4× 1 0.0× 23 1.5× 7 256
William Kammerer United States 8 71 0.7× 41 1.0× 4 0.3× 5 0.3× 14 336
Sawyer W Crosby United States 5 48 0.4× 45 1.1× 12 0.8× 7 105
Chris Lewis New Zealand 6 26 0.2× 25 0.6× 16 1.1× 23 1.5× 11 225
Stanislas Okitotsho Wembonyama Democratic Republic of the Congo 11 12 0.1× 28 0.7× 37 2.5× 10 0.7× 39 406
Elle Pope United States 7 97 0.9× 43 1.0× 24 1.6× 15 257
Mark Moses United States 6 51 0.5× 45 1.1× 49 3.3× 8 174
Mario Tristán Spain 7 23 0.2× 25 0.6× 4 0.3× 6 0.4× 12 198
Léon Nshimyumukiza Canada 11 41 0.4× 15 0.4× 1 0.0× 79 5.3× 4 0.3× 17 302

Countries citing papers authored by S. Van Der Linden

Since Specialization
Citations

This map shows the geographic impact of S. Van Der Linden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Van Der Linden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Van Der Linden more than expected).

Fields of papers citing papers by S. Van Der Linden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Van Der Linden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Van Der Linden. The network helps show where S. Van Der Linden may publish in the future.

Co-authorship network of co-authors of S. Van Der Linden

This figure shows the co-authorship network connecting the top 25 collaborators of S. Van Der Linden. A scholar is included among the top collaborators of S. Van Der Linden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Van Der Linden. S. Van Der Linden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zhang, Xinrong, et al.. (2025). Projected Trends in Metabolic Dysfunction–Associated Steatotic Liver Disease Mortality Through 2040. JAMA Network Open. 8(6). e2516367–e2516367. 3 indexed citations
2.
Heijde, Désirée van der, et al.. (2003). [The value of joint general practitioner and rheumatologist consultations in primary care patients].. PubMed. 147(10). 447–50. 2 indexed citations
3.
Linden, S. Van Der. (2002). Standing Committee on Epidemiology and Health Services Research. Annals of the Rheumatic Diseases. 61(12). 1115–1115. 4 indexed citations
4.
Verhoeven, Arco C., Maarten Boers, J.M. te Koppele, et al.. (2001). Reliability of spot samples for assessment of urinary excretion of pyridinoline in patients with rheumatoid arthritis.. PubMed. 19(1). 78–80. 1 indexed citations
5.
Mölken, Maureen Rutten‐van, et al.. (1995). Methodological Issues of Patient Utility Measurement Experience From Two Clinical Trials. Medical Care. 33(9). 922–937. 96 indexed citations
6.
Linden, S. Van Der, et al.. (1995). A framework to classify burden of illness measures.. PubMed. 22(6). 1185–7. 2 indexed citations
7.
Bakker, C & S. Van Der Linden. (1995). Health related utility measurement: an introduction.. PubMed. 22(6). 1197–9. 52 indexed citations
8.
Blaauw, Ivo de, Ben A. C. Dijkmans, Paul A.D. Bouma, & S. Van Der Linden. (1993). Rational diagnosis and treatment in unclassified arthritis: how clinical data may guide requests for Lyme serology and antibiotic treatment.. Annals of the Rheumatic Diseases. 52(3). 206–210. 5 indexed citations
9.
Blaauw, Ivo de, et al.. (1991). Lyme arthritis in The Netherlands: a nationwide survey among rheumatologists.. PubMed. 18(12). 1819–22. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026